Glibenclamide improves postprandial hypertriglyceridaemia in type II diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels. - Skrapari,I.; Perrea,D.; Ionnidis,I.; Karabina,S.AP.; Elisaf,M.; Tselepis,A.D.; Karagiannacos,P.; Katsilambros,N. (Diabet Med, 2001)